Branwen has a PhD in neuroscience, which was conducted at the Garvan Institute of Medical Research in Sydney, and an MSc in molecular biology (plant pathogens) from Massey University, NZ. She has extensive strategic and project management experience as well as broad scientific knowledge as a result of working in non-academic roles in London and Sydney. Branwen consulted to the pharmaceutical industry and Nature Publishing Group before returning to academia joining AusGEM, a research partnership between the University of Technology Sydney and the NSW Department of Primary Industries.
This led to the co-founding of the OUTBREAK project. OUTBREAK is a world first, high-tech decision support system that uses AI to track, trace and tackle drug-resistant infections in real-time. The UTS-led transdisciplinary team includes more than a dozen academic, industry and government partner organisations. Initial funding was through the Medical Research Futures Fund Frontiers program (stage 1).
Experience
-
2021–presentResearch Director, CSIRO
-
2019–2021Associate Professor, UTS
Education
-
2003UNSW, PhD
-
1997Massey University, MSc
Publications
-
2020Genomic Surveillance for One Health Antimicrobial Resistance: Understanding Human, Animal, and Environmental Reservoirs and Transmission. Antibiotic Resistance in the Environment,
-
2020The COVID-19 pandemic: considerations for the waste and wastewater services sector. Case studies in chemical and environmental engineering,
-
2019A One Health genomic approach to antimicrobial resistance is essential for generating relevant data for a holistic assessment of the biggest threat to public health.,
Professional Memberships
- The Australian Society for Microbiology
- Australian Science Communicators
- Women in STEMM
- The Australasian Genomic Technologies Association
- Sydney, Australia
- Website
- @OneHealthAu
- Article Feed
- ORCID
- Joined
